Dr. Leddon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3199 Highland Ave
Cincinnati, OH 45219Phone+1 513-584-4505Fax+1 513-584-0468
Education & Training
- University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2017 - 2019
- University of Cincinnati College of MedicineClass of 2016
Certifications & Licensure
- OH State Medical License 2016 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 8 citationsPhase II Trial of Adjuvant Nivolumab Following Salvage Resection in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck.Jennifer L Leddon, Shuchi Gulati, Sulsal Haque, Casey Allen, Sarah Palackdharry
Clinical Cancer Research. 2022-08-15 - 4 citationsHypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors.Jennifer L. Leddon, Martina Chirra, Andrew J. Frankart, Arushi Agrawal, Logan Roof
The Laryngoscope. 2021-02-20 - 36 citationsMyelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune MicroenvironmentNicholas L Denton, Chun-Yu Chen, Brian Hutzen, Mark A. Currier, Thomas Scott
Molecular Therapy Oncolytics. 2018-12-21
Press Mentions
- UC Doctors Study if Vaccines Can Prevent Lung Cancer RecurrenceDecember 2nd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: